Income Statement Shenyang Xingqi Pharmaceutical Co.,Ltd.

Equities

300573

CNE100002DV1

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 2024-09-18			5-day change	1st Jan Change
69.85 ^CNY	-2.82%		-8.43%	-46.36%

08-29	Shenyang Xingqi Pharmaceutical Co.,Ltd. Proposes Profit Distribution for First Half of 2024	CI
08-28	Shenyang Xingqi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024	CI

6dbf15f432c3fa.Teq_eFs4hJTWrrca2Qvj7anPYPAdNRMUWrYiArN6i0Q.OIbTO2tR5sal-IZFmEGCpdOfVLMtaiNHMfdHNt8RwgAX2fsvNWfe1br40A

Published financial data: SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019	2020	2021	2022	2023
Revenues	539M	683M	1.02B	1.23B	1.44B
Other Revenues, Total	3.78M	5.46M	3.6M	23.2M	27.86M
Total Revenues	542M	689M	1.03B	1.25B	1.47B
Cost of Goods Sold, Total	147M	188M	229M	270M	340M
Gross Profit	395M	501M	799M	980M	1.13B
Selling General & Admin Expenses, Total	292M	321M	457M	595M	690M
Provision for Bad Debts	2.23M	1.04M	-187K	926K	3.03M
R&D Expenses	53.97M	63.19M	88.45M	146M	167M
Other Operating Expenses	9.53M	9.81M	13.8M	6.66M	7.16M
Other Operating Expenses, Total	358M	395M	559M	749M	867M
Operating Income	37.49M	105M	240M	231M	260M
Interest Expense, Total	-4.46M	-5.94M	-5.99M	-937K	-1.44M
Interest And Investment Income	152K	221K	3.98M	9.93M	7.91M
Net Interest Expenses	-4.3M	-5.72M	-2.02M	9M	6.48M
Currency Exchange Gains (Loss)	11.13K	-22.54K	-125K	-89.63K	200K
Other Non Operating Income (Expenses)	-595K	-546K	-1.05M	-917K	-1.15M
EBT, Excl. Unusual Items	32.6M	99.14M	237M	239M	265M
Impairment of Goodwill	-	-	-	-	-
Gain (Loss) On Sale Of Assets	8.68K	-77.81K	5.16M	421K	-37.53K
Asset Writedown	-	-	-1.68K	-4.9K	-
Other Unusual Items	3.2M	3.48M	1.26M	-5.88M	-421K
EBT, Incl. Unusual Items	35.82M	103M	244M	234M	265M
Income Tax Expense	6.31M	9.08M	34.43M	22.03M	24.96M
Earnings From Continuing Operations	29.51M	93.46M	209M	212M	240M
Net Income to Company	29.51M	93.46M	209M	212M	240M
Minority Interest	6.38M	-5.48M	-14.41M	-	-
Net Income - (IS)	35.89M	87.98M	195M	212M	240M
Net Income to Common Incl Extra Items	35.89M	87.98M	195M	212M	240M
Net Income to Common Excl. Extra Items	35.89M	87.98M	195M	212M	240M
Per Share Items
Net EPS - Basic	0.23	0.56	1.22	1.23	1.38
Basic EPS - Continuing Operations	0.23	0.56	1.22	1.23	1.38
Basic Weighted Average Shares Outstanding	156M	158M	160M	172M	174M
Net EPS - Diluted	0.23	0.55	1.21	1.23	1.38
Diluted EPS - Continuing Operations	0.23	0.55	1.21	1.23	1.38
Diluted Weighted Average Shares Outstanding	156M	160M	161M	172M	174M
Normalized Basic EPS	0.17	0.36	0.84	0.87	0.95
Normalized Diluted EPS	0.17	0.35	0.83	0.87	0.95
Dividend Per Share	0.06	0.13	0.33	0.77	2.64
Payout Ratio	55.72	18.41	24.21	38.19	74.36
Supplemental Items
EBITDA	77.72M	150M	297M	295M	338M
EBITA	38.03M	106M	241M	232M	261M
EBIT	37.49M	105M	240M	231M	260M
EBITDAR	79.73M	152M	299M	296M	339M
Total Revenues (As Reported)	542M	689M	1.03B	1.25B	1.47B
Effective Tax Rate - (Ratio)	17.61	8.86	14.14	9.43	9.42
Current Domestic Taxes	13.86M	9.55M	-	-	-
Total Current Taxes	13.86M	9.55M	37.03M	27.66M	24.22M
Deferred Domestic Taxes	-7.55M	-469K	-	-	-
Total Deferred Taxes	-7.55M	-469K	-2.59M	-5.63M	736K
Normalized Net Income	26.76M	56.48M	134M	149M	166M
Interest on Long-Term Debt	-	-	11.31M	599K	557K
Supplemental Operating Expense Items
Advertising Expense	5.14M	6.89M	5.22M	13M	13.81M
Marketing Expenses	-	-	-	-	-
Selling and Marketing Expenses	219M	244M	338M	463M	535M
General and Administrative Expenses	71.28M	75.46M	118M	132M	154M
Research And Development Expense From Footnotes	53.97M	63.19M	88.45M	146M	167M
Net Rental Expense, Total	2.01M	1.66M	1.89M	534K	1.38M
Imputed Operating Lease Interest Expense	1.02M	930K	947K	64.05K	342K
Imputed Operating Lease Depreciation	986K	735K	943K	470K	1.04M
Maintenance & Repair Expenses, Total	-	-	-	-	-
Stock-Based Comp., COGS (Total)	-	-	-	-	1.68M
Stock-Based Comp., R&D Exp. (Total)	-	-	-	-	5.2M
Stock-Based Comp., S&M Exp. (Total)	-	-	-	-	10.29M
Stock-Based Comp., G&A Exp. (Total)	8.92M	4.19M	13.31M	11.01M	6.25M
Total Stock-Based Compensation	8.92M	4.19M	13.31M	11.01M	23.42M

Fiscal Period: December	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	49.96M	37.22M	686M	515M	480M
Total Cash And Short Term Investments	49.96M	37.22M	686M	515M	480M
Accounts Receivable, Total	130M	158M	171M	195M	252M
Other Receivables	1.91M	3.15M	5.84M	4.62M	3.93M
Total Receivables	132M	161M	176M	200M	256M
Inventory	79.87M	68.31M	92.33M	122M	136M
Other Current Assets, Total	19.64M	27.32M	29.27M	27.87M	32.71M
Total Current Assets	282M	294M	984M	865M	905M
Gross Property Plant And Equipment	718M	812M	892M	1.1B	1.32B
Accumulated Depreciation	-244M	-285M	-343M	-403M	-484M
Net Property Plant And Equipment	474M	528M	549M	696M	837M
Long-term Investments	2.2M	-	-	-	-
Other Intangibles, Total	23.84M	23.83M	22.83M	27.66M	78.29M
Deferred Tax Assets Long-Term	13.28M	33.87M	30.45M	23.77M	38.57M
Deferred Charges Long-Term	9.02M	28.22M	60.77M	105M	119M
Other Long-Term Assets, Total	48M	57.67M	39.78M	65.39M	45.68M
Total Assets	852M	966M	1.69B	1.78B	2.02B
Liabilities
Accounts Payable, Total	26.52M	6.67M	13.31M	19.46M	17.57M
Accrued Expenses, Total	67.13M	91.39M	109M	104M	125M
Short-term Borrowings	90M	80M	100M	-	70.06M
Current Portion of Long-Term Debt	-	-	-	-	-
Current Portion of Leases	-	-	4.18M	7.12M	6.87M
Current Income Taxes Payable	8.77M	-	11.69M	-	5.74M
Unearned Revenue Current, Total	-	5.11M	6.11M	2.01M	6.55M
Other Current Liabilities	28.65M	29.34M	22.63M	19.89M	27.98M
Total Current Liabilities	221M	212M	267M	152M	260M
Long-Term Debt	-	-	-	-	-
Long-Term Leases	-	-	7.1M	6.69M	2.22M
Unearned Revenue Non Current	56.4M	59.15M	68.42M	71.5M	71.58M
Total Liabilities	277M	272M	342M	231M	334M
Common Stock, Total	82.43M	82.37M	88.1M	88.56M	125M
Additional Paid In Capital	256M	288M	783M	852M	891M
Retained Earnings	249M	327M	479M	611M	674M
Treasury Stock	-19.56M	-13.26M	-5.28M	-	-
Comprehensive Income and Other	-	-2.2M	-	-	-
Total Common Equity	569M	682M	1.34B	1.55B	1.69B
Minority Interest	6.39M	11.87M	-	-	-
Total Equity	575M	694M	1.34B	1.55B	1.69B
Total Liabilities And Equity	852M	966M	1.69B	1.78B	2.02B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	146M	161M	173M	174M	174M
ECS Total Common Shares Outstanding	146M	161M	173M	174M	174M
Book Value / Share	3.9	4.23	7.79	8.94	9.69
Tangible Book Value	545M	658M	1.32B	1.52B	1.61B
Tangible Book Value Per Share	3.74	4.08	7.65	8.78	9.24
Total Debt	90M	80M	111M	13.81M	79.15M
Net Debt	40.04M	42.78M	-575M	-502M	-401M
Debt Equivalent Oper. Leases	16.07M	13.32M	15.13M	4.27M	11.07M
Minority Interest, Total (Incl. Fin. Div)	6.39M	11.87M	-	-	-
Account Code - Inventory Valuation	6	6	6	3	6
Inventories - Raw Materials, Total	44.86M	41.14M	48.07M	54.96M	56.27M
Inventories - Work In Process, Total	18.93M	15.81M	21.37M	34.33M	37.89M
Inventories - Finished Goods, Total	16.21M	11.03M	25.12M	33.67M	46.55M
Inventories - Others	3.46M	4.64M	4.78M	8.3M	8.67M
Buildings, Total	343M	347M	350M	471M	477M
Machinery, Total	319M	439M	481M	534M	712M
Full Time Employees	987	1.1K	-	1.76K	2K
Accumulated Allowance for Doubtful Accounts (Supple)	6.34M	7.38M	6.97M	7.89M	10.93M

Fiscal Period: December	2019	2020	2021	2022	2023
Net Income	35.89M	87.98M	195M	212M	240M
Depreciation & Amortization - CF	39.69M	44.29M	66.04M	72.08M	84.89M
Amortization of Goodwill and Intangible Assets - (CF)	534K	534K	534K	534K	1.39M
Depreciation & Amortization, Total	40.23M	44.82M	66.57M	72.61M	86.28M
Amortization of Deferred Charges, Total - (CF)	3.43M	4.03M	6.92M	7.42M	7.06M
(Gain) Loss From Sale Of Asset	-8.68K	77.81K	-5.16M	-421K	37.53K
(Gain) Loss on Sale of Investments - (CF)	-	-	-3.14M	-	-
Asset Writedown & Restructuring Costs	4.76M	3.92M	1.68K	4.9K	-
Provision and Write-off of Bad Debts	-	-	-187K	926K	3.03M
Other Operating Activities, Total	-1.94M	11.44M	24.49M	5.53M	10.23M
Change In Accounts Receivable	-47.05M	-61.27M	-33.43M	-37.51M	-104M
Change In Inventories	-25.68M	8.71M	-27.8M	-34.35M	-22.05M
Change In Accounts Payable	63.08M	18.72M	73.27M	23.51M	73.17M
Change In Deferred Taxes	-7.55M	-469K	-2.59M	-5.62M	736K
Change in Other Net Operating Assets	8.92M	4.19M	13.31M	42.47M	23.42M
Cash from Operations	74.08M	122M	307M	286M	318M
Capital Expenditure	-69.98M	-108M	-95.06M	-299M	-262M
Sale of Property, Plant, and Equipment	31.41K	4.53K	19.03M	76.76K	21.24K
Cash Acquisitions	-	-	-	-	-
Divestitures	-	-	1.26M	-	-
Investment in Marketable and Equity Securities, Total	-	-	-130M	-	-
Other Investing Activities, Total	-	-	3M	-	-
Cash from Investing	-69.94M	-108M	-202M	-299M	-262M
Short Term Debt Issued, Total	143M	120M	100M	20M	70M
Long-Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	143M	120M	100M	20M	70M
Short Term Debt Repaid, Total	-103M	-130M	-80M	-120M	-
Long-Term Debt Repaid, Total	-	-	-8.7M	-6.17M	-7.67M
Total Debt Repaid	-103M	-130M	-88.7M	-126M	-7.67M
Issuance of Common Stock	-	-	580M	27.56M	25.3M
Repurchase of Common Stock	-	-536K	-272K	-	-
Common Dividends Paid	-20M	-16.2M	-47.13M	-80.84M	-178M
Common & Preferred Stock Dividends Paid	-20M	-16.2M	-47.13M	-80.84M	-178M
Other Financing Activities, Total	-14.21M	11.66M	-5.95M	1.02M	6.69M
Cash from Financing	5.79M	-15.08M	538M	-158M	-84.17M
Foreign Exchange Rate Adjustments	11.13K	-22.54K	-125K	-89.63K	200K
Net Change in Cash	9.94M	-1.09M	643M	-171M	-28.34M
Supplemental Items
Cash Interest Paid	4.46M	-	-	-	-
Cash Income Tax Paid (Refund)	65.2M	73.86M	103M	134M	110M
Levered Free Cash Flow	9.79M	-16.68M	127M	-133M	-20.83M
Unlevered Free Cash Flow	12.58M	-12.97M	131M	-133M	-19.94M
Change In Net Working Capital	-6.55M	23.76M	10.91M	68.98M	37.19M
Net Debt Issued / Repaid	40M	-10M	11.3M	-106M	62.33M

Fiscal Period: December	2019	2020	2021	2022	2023
Profitability
Return on Assets	3	7.25	11.32	8.33	8.53
Return on Total Capital	3.69	9.16	13.47	9.56	9.74
Return On Equity %	5.23	14.73	20.52	14.62	14.81
Return on Common Equity	6.44	14.07	19.21	14.62	14.81
Margin Analysis
Gross Profit Margin %	72.87	72.72	77.72	78.39	76.81
SG&A Margin	53.84	46.66	44.41	47.64	47
EBITDA Margin %	14.33	21.82	28.88	23.64	23.02
EBITA Margin %	7.01	15.39	23.43	18.54	17.81
EBIT Margin %	6.91	15.31	23.38	18.5	17.71
Income From Continuing Operations Margin %	5.44	13.57	20.34	16.94	16.36
Net Income Margin %	6.62	12.77	18.94	16.94	16.36
Net Avail. For Common Margin %	6.62	12.77	18.94	16.94	16.36
Normalized Net Income Margin	4.93	8.2	13.02	11.96	11.3
Levered Free Cash Flow Margin	1.81	-2.42	12.38	-10.66	-1.42
Unlevered Free Cash Flow Margin	2.32	-1.88	12.75	-10.62	-1.36
Asset Turnover
Asset Turnover